March 04, 2026

Innovations Shaping Women’s Cancer Care in 2026

As we move through 2026, new technologies and refined surgical techniques are transforming outcomes for women facing cancer diagnoses.

Baptist Health South Florida

February 27, 2026

Novel Therapies and Multidisciplinary Strategies in Metastatic Triple-Positive Breast Cancer

Explore the latest insights on treating metastatic triple-positive breast cancer, emphasizing multimodal therapy and adverse event management, as discussed by oncology experts at JADPRO Live 2025.

JADPRO

February 27, 2026

2024–2025 Drug Updates in Solid Tumors

Explore the latest in solid tumor therapies that prioritize patient quality of life, presented by Dr. Kevin Y. Chen at JADPRO Live 2025.

JADPRO

February 25, 2026

Can Induction Improve Survival in High-Risk, Locally Advanced Cervical Cancer?

Rates of overall and progression-free survival for locally advanced cervical cancer have risen significantly since 2024, when the FDA approved the use of pembrolizumab (brand name Keytruda) with chemoradiation for stage 3-4A disease.

Roswell Park Comprehensive Cancer Center

February 24, 2026

Single-Port Robotic Surgery Now Helps Head and Neck Surgeons Treat Hard-to-Reach Tumors

A Keck Medicine of USC head and neck surgeon explains the advantages — as well as remaining challenges.

Keck Medicine of USC

February 15, 2026

Dana-Farber Research News 02.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from January 16 - 31.

Dana-Farber

February 13, 2026

World Leaders in Gamma Knife Radiosurgery, Roswell Park Experts Expand Benefits and Access

Since Roswell Park Comprehensive Cancer Center first began offering Gamma Knife radiosurgery 27 years ago, the cancer center has emerged as a world leader in the procedure.

Roswell Park Comprehensive Cancer Center

February 10, 2026

Dana-Farber Launches Colorectal Cancer Screening Program in Central Asia

Dana-Farber Cancer Institute's Center for Global Health launched the first colorectal cancer screening program in Central Asia this week, partnering with Uzbekistan’s Ministry of Health and National Cancer Center to pilot a sustainable, early detection model that could be scaled across the region.

Dana-Farber

February 06, 2026

Baptist Health Miami Cancer Institute Names Bruna Pellini, M.D., Chief of Thoracic Medical Oncology

Board-certified thoracic oncologist Bruna Pellini, M.D., has been named chief of thoracic medical oncology at Baptist Health Miami Cancer Institute.

Baptist Health South Florida

February 03, 2026

Three Dana-Farber Cancer Institute scientific leaders elected as Fellows of the American Association for Cancer Research (AACR) Academy Class of 2026

Dr. Alice Shaw, Dr. Kimberly Stegmaier and Dr. Matthew Vander Heiden have been elected as Fellows of the American Association for Cancer Research (AACR) Academy Class of 2026.

Dana-Farber